The frequency of mutation in the GABRA6, GABRA1, and GABRB2 genes was significantly higher than that detected for other cell-cycle- and cell-proliferation-related genes; furthermore, their co-occurrence in patients with cancer was examined. Here, GABRB2 is linked to cancer.